drugset / Trial / NCT05156281
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Timeline
- Start
- 2021-12-13
- Primary completion
- 2026-07-23
- Completion
- 2030-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remibrutinib | Small molecule | — | Oral |
| Comparator | Teriflunomide | Small molecule | — | Oral |